{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:01:57Z","timestamp":1784512917615,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371949"],"award-info":[{"award-number":["82371949"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06001-6","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:54:46Z","timestamp":1779677686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of cardiovascular-kidney-metabolic burden with recurrence after first ablation in patients with persistent atrial fibrillation"],"prefix":"10.1186","volume":"26","author":[{"given":"Peiyang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinguang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"6001_CR1","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45:3314\u2013414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176.","journal-title":"Eur Heart J"},{"key":"6001_CR2","doi-asserted-by":"publisher","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149. https:\/\/doi.org\/10.1161\/CIR.0000000000001193.","DOI":"10.1161\/CIR.0000000000001193"},{"key":"6001_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/ehjqcco\/qcad037","volume":"9","author":"L Ngo","year":"2023","unstructured":"Ngo L, Lee XW, Elwashahy M, et al. Freedom from atrial arrhythmia and other clinical outcomes at 5 years and beyond after catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Eur Heart J - Qual Care Clin Outcomes. 2023;9:447\u201358. https:\/\/doi.org\/10.1093\/ehjqcco\/qcad037.","journal-title":"Eur Heart J - Qual Care Clin Outcomes"},{"key":"6001_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1001\/jama.2024.24438","volume":"333","author":"C Sang","year":"2025","unstructured":"Sang C, Liu Q, Lai Y, et al. Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF: The PROMPT-AF Randomized Clinical Trial. JAMA. 2025;333:381. https:\/\/doi.org\/10.1001\/jama.2024.24438.","journal-title":"JAMA"},{"key":"6001_CR5","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.jacc.2024.02.050","volume":"83","author":"MD McCauley","year":"2024","unstructured":"McCauley MD, Iacobellis G, Li N, et al. Targeting the Substrate for Atrial Fibrillation. J Am Coll Cardiol. 2024;83:2015\u201327. https:\/\/doi.org\/10.1016\/j.jacc.2024.02.050.","journal-title":"J Am Coll Cardiol"},{"key":"6001_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jjcc.2024.05.007","volume":"85","author":"T Yamaguchi","year":"2025","unstructured":"Yamaguchi T. Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective. J Cardiol. 2025;85:47\u201355. https:\/\/doi.org\/10.1016\/j.jjcc.2024.05.007.","journal-title":"J Cardiol"},{"key":"6001_CR7","doi-asserted-by":"publisher","first-page":"1327387","DOI":"10.3389\/fcvm.2023.1327387","volume":"10","author":"B Vandenberk","year":"2024","unstructured":"Vandenberk B, Haemers P, Morillo C. The autonomic nervous system in atrial fibrillation\u2014pathophysiology and non-invasive assessment. Front Cardiovasc Med. 2024;10:1327387. https:\/\/doi.org\/10.3389\/fcvm.2023.1327387.","journal-title":"Front Cardiovasc Med"},{"key":"6001_CR8","doi-asserted-by":"publisher","first-page":"103220","DOI":"10.1016\/j.cpcardiol.2025.103220","volume":"51","author":"S Tonso","year":"2026","unstructured":"Tonso S, Saccomani F, Casta\u00f1o B, et al. Left atrial volume measured by Cardiac CT as an independent predictor of atrial fibrillation recurrence following catheter ablation. Curr Probl Cardiol. 2026;51:103220. https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103220.","journal-title":"Curr Probl Cardiol"},{"key":"6001_CR9","doi-asserted-by":"publisher","first-page":"e003251","DOI":"10.1136\/openhrt-2025-003251","volume":"12","author":"H Ishiguchi","year":"2025","unstructured":"Ishiguchi H, Yoshiga Y, Fukuda M, et al. Integrating pre-ablation and post-ablation B-type natriuretic peptide to identify high-risk population for long-term adverse events and arrhythmic recurrence in persistent atrial fibrillation. Open Heart. 2025;12:e003251. https:\/\/doi.org\/10.1136\/openhrt-2025-003251.","journal-title":"Open Heart"},{"key":"6001_CR10","doi-asserted-by":"publisher","first-page":"e25295","DOI":"10.1016\/j.heliyon.2024.e25295","volume":"10","author":"P Escribano","year":"2024","unstructured":"Escribano P, R\u00f3denas J, Garc\u00eda M, et al. Combination of frequency- and time-domain characteristics of the fibrillatory waves for enhanced prediction of persistent atrial fibrillation recurrence after catheter ablation. Heliyon. 2024;10:e25295. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25295.","journal-title":"Heliyon"},{"key":"6001_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, et al. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach. Chest. 2010;137:263\u201372. https:\/\/doi.org\/10.1378\/chest.09-1584.","journal-title":"Chest"},{"key":"6001_CR12","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148:1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"key":"6001_CR13","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011\u20132020. JAMA. 2024;331:1858. https:\/\/doi.org\/10.1001\/jama.2024.6892.","journal-title":"JAMA"},{"key":"6001_CR14","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.jhepr.2024.101171","volume":"6","author":"J Boeckmans","year":"2024","unstructured":"Boeckmans J, Michel M, Gieswinkel A, et al. Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study. JHEP Rep. 2024;6:101171. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101171.","journal-title":"JHEP Rep"},{"key":"6001_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.yjmcc.2025.06.002","volume":"205","author":"JA Navarro-Garcia","year":"2025","unstructured":"Navarro-Garcia JA, Keefe JA, Song J, et al. Mechanisms underlying atrial fibrillation in chronic kidney disease. J Mol Cell Cardiol. 2025;205:37\u201351. https:\/\/doi.org\/10.1016\/j.yjmcc.2025.06.002.","journal-title":"J Mol Cell Cardiol"},{"key":"6001_CR16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.hroo.2024.09.003","volume":"5","author":"M Bannehr","year":"2024","unstructured":"Bannehr M, Georgi C, Edlinger C, et al. Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation. Heart Rhythm O2. 2024;5:770\u20137. https:\/\/doi.org\/10.1016\/j.hroo.2024.09.003.","journal-title":"Heart Rhythm O2"},{"key":"6001_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12933-019-0928-8","volume":"18","author":"Y-H Chan","year":"2019","unstructured":"Chan Y-H, Chang G-J, Lai Y-J, et al. Atrial fibrillation and its arrhythmogenesis associated with insulin resistance. Cardiovasc Diabetol. 2019;18:125. https:\/\/doi.org\/10.1186\/s12933-019-0928-8.","journal-title":"Cardiovasc Diabetol"},{"key":"6001_CR18","doi-asserted-by":"publisher","first-page":"1700730","DOI":"10.3389\/fcvm.2025.1700730","volume":"12","author":"T Huang","year":"2026","unstructured":"Huang T, Fang Z, Zhang Q, et al. Insulin resistance and atrial fibrillation: from disease onset to post-ablation outcomes: a systematic review and meta-analysis. Front Cardiovasc Med. 2026;12:1700730. https:\/\/doi.org\/10.3389\/fcvm.2025.1700730.","journal-title":"Front Cardiovasc Med"},{"key":"6001_CR19","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/europace\/euaa041","volume":"22","author":"J Dretzke","year":"2020","unstructured":"Dretzke J, Chuchu N, Agarwal R, et al. Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models. EP Europace. 2020;22:748\u201360. https:\/\/doi.org\/10.1093\/europace\/euaa041.","journal-title":"EP Europace"},{"key":"6001_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-024-02219-w","volume":"23","author":"S Jia","year":"2024","unstructured":"Jia S, Yin Y, Mou X, et al. Association between triglyceride\u2013glucose index trajectories and radiofrequency ablation outcomes in patients with stage 3D atrial fibrillation. Cardiovasc Diabetol. 2024;23:121. https:\/\/doi.org\/10.1186\/s12933-024-02219-w.","journal-title":"Cardiovasc Diabetol"},{"key":"6001_CR21","doi-asserted-by":"publisher","unstructured":"Ghoshouni H, Sepehri Shamloo A, Mirjalili SR et al. Association between surrogate insulin resistance markers and postablation atrial fibrillation recurrence: A systematic review and meta-analysis. Heart Rhythm 2025:S1547527125023987. https:\/\/doi.org\/10.1016\/j.hrthm.2025.04.050","DOI":"10.1016\/j.hrthm.2025.04.050"},{"key":"6001_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/europace\/eux013","volume":"20","author":"A Njoku","year":"2018","unstructured":"Njoku A, Kannabhiran M, Arora R, et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. EP Europace. 2018;20:33\u201342. https:\/\/doi.org\/10.1093\/europace\/eux013.","journal-title":"EP Europace"},{"key":"6001_CR23","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148:1636\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000001186.","journal-title":"Circulation"},{"key":"6001_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.tcm.2025.01.002","volume":"35","author":"PE Papakonstantinou","year":"2025","unstructured":"Papakonstantinou PE, Rivera-Caravaca JM, Chiarito M, et al. Atrial fibrillation versus atrial myopathy in thrombogenesis: two sides of the same coin? Trends Cardiovasc Med. 2025;35:271\u201381. https:\/\/doi.org\/10.1016\/j.tcm.2025.01.002.","journal-title":"Trends Cardiovasc Med"},{"key":"6001_CR25","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3389\/fphys.2018.01726","volume":"9","author":"H Qiu","year":"2018","unstructured":"Qiu H, Ji C, Liu W, et al. Chronic Kidney Disease Increases Atrial Fibrillation Inducibility: Involvement of Inflammation, Atrial Fibrosis, and Connexins. Front Physiol. 2018;9:1726. https:\/\/doi.org\/10.3389\/fphys.2018.01726.","journal-title":"Front Physiol"},{"key":"6001_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12874-021-01426-3","volume":"21","author":"JJM Rijnhart","year":"2021","unstructured":"Rijnhart JJM, Lamp SJ, Valente MJ, et al. Mediation analysis methods used in observational research: a scoping review and recommendations. BMC Med Res Methodol. 2021;21:226\u201342. https:\/\/doi.org\/10.1186\/s12874-021-01426-3.","journal-title":"BMC Med Res Methodol"},{"key":"6001_CR27","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3390\/jcm14030809","volume":"14","author":"A-E Karanikola","year":"2025","unstructured":"Karanikola A-E, Tzortzi M, Kordalis A, et al. Clinical, Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation Recurrence After Pulmonary Vein Isolation. J Clin Med. 2025;14:809\u201329. https:\/\/doi.org\/10.3390\/jcm14030809.","journal-title":"J Clin Med"},{"key":"6001_CR28","doi-asserted-by":"publisher","first-page":"e031029","DOI":"10.1161\/JAHA.123.031029","volume":"13","author":"MA El-Harasis","year":"2024","unstructured":"El-Harasis MA, Quintana JA, Martinez\u2010Parachini JR, et al. Recurrence After Atrial Fibrillation Ablation and Investigational Biomarkers of Cardiac Remodeling. JAHA. 2024;13:e031029. https:\/\/doi.org\/10.1161\/JAHA.123.031029.","journal-title":"JAHA"},{"key":"6001_CR29","doi-asserted-by":"publisher","first-page":"euae204","DOI":"10.1093\/europace\/euae204","volume":"26","author":"A Goette","year":"2024","unstructured":"Goette A, Corradi D, Dobrev D, et al. Atrial cardiomyopathy revisited\u2014evolution of a concept: a clinical consensus statement of the European heart rhythm association (EHRA) of the ESC, the heart rhythm society (HRS), the Asian pacific heart rhythm society (APHRS), and the latin american heart rhythm society (LAHRS). Europace. 2024;26:euae204. https:\/\/doi.org\/10.1093\/europace\/euae204.","journal-title":"Europace"},{"key":"6001_CR30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/CIRCRESAHA.123.324001","volume":"134","author":"A Curaj","year":"2024","unstructured":"Curaj A, Vanholder R, Loscalzo J, et al. Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways. Circul Res. 2024;134:592\u2013613. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.324001.","journal-title":"Circul Res"},{"key":"6001_CR31","doi-asserted-by":"publisher","first-page":"e032277","DOI":"10.1161\/JAHA.123.032277","volume":"13","author":"R Sha","year":"2024","unstructured":"Sha R, Baines O, Hayes A, et al. Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options. JAHA. 2024;13:e032277. https:\/\/doi.org\/10.1161\/JAHA.123.032277.","journal-title":"JAHA"},{"key":"6001_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/ijms26010209","volume":"26","author":"P Karakasis","year":"2024","unstructured":"Karakasis P, Theofilis P, Vlachakis PK, et al. Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets. IJMS. 2024;26:209. https:\/\/doi.org\/10.3390\/ijms26010209.","journal-title":"IJMS"},{"key":"6001_CR33","doi-asserted-by":"publisher","unstructured":"Rangaswami J, Bhalla V, Blair JEA et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation 2019;139. https:\/\/doi.org\/10.1161\/CIR.0000000000000664","DOI":"10.1161\/CIR.0000000000000664"},{"key":"6001_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.acvd.2019.02.006","volume":"112","author":"H Deng","year":"2019","unstructured":"Deng H, Shantsila A, Xue Y, et al. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry. Arch Cardiovasc Dis. 2019;112:420\u20139. https:\/\/doi.org\/10.1016\/j.acvd.2019.02.006.","journal-title":"Arch Cardiovasc Dis"},{"key":"6001_CR35","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1253\/circj.CJ-23-0263","volume":"87","author":"T Kawaji","year":"2023","unstructured":"Kawaji T, Shizuta S, Aizawa T, et al. Prognostic Importance of B-Type Natriuretic Peptide Level in Patients Undergoing Catheter Ablation for Atrial Fibrillation. Circ J. 2023;87:1730\u20139. https:\/\/doi.org\/10.1253\/circj.CJ-23-0263.","journal-title":"Circ J"},{"key":"6001_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jchf.2021.12.005","volume":"10","author":"EM Boorsma","year":"2022","unstructured":"Boorsma EM, Ter Maaten JM, Voors AA, et al. Renal Compression in Heart Failure. JACC: Heart Fail. 2022;10:175\u201383. https:\/\/doi.org\/10.1016\/j.jchf.2021.12.005.","journal-title":"JACC: Heart Fail"},{"key":"6001_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ejhf.1697","volume":"22","author":"W Mullens","year":"2020","unstructured":"Mullens W, Damman K, Testani JM, et al. Evaluation of Kidney Function Throughout the Heart Failure Trajectory \u2013 A Position Statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22:584\u2013603. https:\/\/doi.org\/10.1002\/ejhf.1697.","journal-title":"Eur J Heart Fail"},{"key":"6001_CR38","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamacardio.2025.4007","volume":"10","author":"RK Pathak","year":"2025","unstructured":"Pathak RK, Elliott AD, Lau DH, et al. Aggressive Risk Factor Reduction Study for Atrial Fibrillation Implications for Ablation Outcomes: The ARREST-AF Randomized Clinical Trial. JAMA Cardiol. 2025;10:1295. https:\/\/doi.org\/10.1001\/jamacardio.2025.4007.","journal-title":"JAMA Cardiol"},{"key":"6001_CR39","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","volume":"65","author":"RK Pathak","year":"2015","unstructured":"Pathak RK, Middeldorp ME, Meredith M, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort. J Am Coll Cardiol. 2015;65:2159\u201369. https:\/\/doi.org\/10.1016\/j.jacc.2015.03.002.","journal-title":"J Am Coll Cardiol"},{"key":"6001_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/s12872-025-05078-9","volume":"25","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zhang L, Chen F, et al. SGLT2 inhibitor reduces atrial tachyarrhythmia recurrence post-cryoballoon ablation: a prospective observational cohort study in patients with and without diabetes. BMC Cardiovasc Disord. 2025;25:633. https:\/\/doi.org\/10.1186\/s12872-025-05078-9.","journal-title":"BMC Cardiovasc Disord"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06001-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06001-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06001-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:16:01Z","timestamp":1784510161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06001-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6001"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06001-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Anhui Medical University (Approval No. PJ 2024-13-76) and complied with the Declaration of Helsinki. The requirement for written informed consent was waived because this was a retrospective study using de-identified clinical data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"616"}}